NEW YORK (GenomeWeb News) – Sequenom said today that it has agreed to pay $14 million to shareholders to settle their class action lawsuit against the company.

Sequenom said that the settlement will be funded by insurance proceeds. Additionally, the company has agreed to issue to the plaintiffs a number of shares of Sequenom common stock, to be determined after final approval of the settlement by the US District Court.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.